News

March 15, 2017March 15, 2017

CF Life Expectancy in Canada Is 10 Years Longer Than in US, Study Finds

Cystic Fibrosis, News

People with cystic fibrosis (CF) who live in Canada can statistically anticipate living about 10 years longer than CF patients with similar demographics and disease profiles living in the U.S., ... Read more

March 14, 2017March 14, 2017

Synairgen Reports Positive Data on Potential IPF Treatment

Idiopathic Pulmonary Fibrosis, News

Synairgen recently reported positive data from its ongoing work in partnership with Pharmaxis to develop a lysyl oxidase type 2 enzyme (LOXL2) inhibitor as a new treatment for idiopathic pulmonary fibrosis (IPF). Synairgen is ... Read more

March 13, 2017March 13, 2017

Bed Covers Impervious to Dust Mites Effective in Reducing Asthma Flare-ups in Children

Asthma, News

Bed covers that are impermeable to house dust mites are effective in reducing asthma flare-ups in children, according to new research. The study, “Preventing Severe Asthma Exacerbations in Children: A Randomised ... Read more

March 10, 2017March 10, 2017

Women with High Sex Hormone Levels More Prone to Asthma and Allergies, Researcher Says

Asthma, News

Women with high levels of the sex hormone estrogen are more susceptible to asthma, pollen and food allergies, according to an Austrian researcher who noted that estrogen levels fluctuate with ... Read more

March 9, 2017March 9, 2017

Vertex Acquires Potential CF Therapy, CTP-656, a Deuterium-Modified Form of Kalydeco

Cystic Fibrosis, News

Vertex Pharmaceuticals has signed a $160 million purchase agreement to acquire CTP-656, a potential treatment for cystic fibrosis (CF), from Concert Pharmaceuticals. The agreement covers development and marketing rights worldwide. ... Read more

March 8, 2017March 8, 2017

Broadway Stars Belt Out Songs to Raise Record $250,000 to Fight Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis, News

The 7th Annual Pulmonary Fibrosis Foundation benefit Broadway Belts for PFF! raised a record-breaking $250,000 – a 35 percent increase over last year – to support its work with the pulmonary fibrosis ... Read more

March 7, 2017March 7, 2017

Treatment Seen to Lessen Fibrotic Scarring That Causes Lung Transplants to Fail

Bronchiolitis, COPD, Cystic Fibrosis, Idiopathic Pulmonary Fibrosis, News

Treatment may be able prevent the progressive accumulation of scar tissue (fibrosis) in newly transplanted lungs that eventually cause those organs to fail, researchers at the University of Michigan report. The study, “Autocrine lysophosphatidic ... Read more

March 6, 2017March 6, 2017

Global IPF Survey Finds Two-thirds of Patients Involved in Treatment Decisions

Idiopathic Pulmonary Fibrosis, News

Results from a new global survey of 152 people living with idiopathic pulmonary fibrosis (IPF) showed that while a majority of these patients have been involved in decisions regarding their ... Read more

March 3, 2017March 3, 2017

Study Identifies New Molecular Treatment Candidate for IPF

Idiopathic Pulmonary Fibrosis, News

Researchers have found that the activity of a protein, called heat shock protein 90 (Hsp90), is elevated in lung cells of patients with idiopathic pulmonary fibrosis (IPF). They also identified ... Read more

March 2, 2017March 2, 2017

Class of IV Antibiotics for Lung Infections Tied to Risk of Hearing Loss in CF Patients

Cystic Fibrosis, News

A class of antibiotics commonly used by people with cystic fibrosis (CF) was found to significantly increase the risk of permanent hearing loss in these patients when given at high dosages ... Read more